Table V.
Results of allograft reconstruction
| Studies, n | 9 |
| Reconstructions, n | 133 |
| Metastatic disease, n (%) | 10 (7) |
| Primary malignancy, n (%) | 123 (93) |
| Mean age in yrs, n (range) | 42 (5 to 71) |
| Male patients, n (%) | 63 (63) |
| Mean follow-up in yrs, n (range) | 5.8 (0.8 to 19) |
| MSTS score at final follow-up, % | 72 |
| Patient mortality, n (%) | |
| AWD | 8 (6) |
| NED | 55 (41.4) |
| DOD | 37 (27.8) |
| Complications, n (%) | |
| Infection | 20 (15) |
| Local recurrence | 15 (11) |
| Dislocation | 10 (8) |
| Wound necrosis | 7 (5) |
| Prosthesis migration/failure | 6 (5) |
| Fracture | 5 (4) |
MSTS, Muskoskeletal Tumor Society; AWD, alive with disease; NED, no evidence of disease; DOD, dead of disease